Biomedical Product and Materials Evaluation
portes grátis
Biomedical Product and Materials Evaluation
Standards and Ethics
Mohanan, P.V.
Elsevier Science Publishing Co Inc
01/2022
806
Mole
Inglês
9780128239667
15 a 20 dias
1000
Descrição não disponível.
1. Materials for medical products
2. Ethical issues in animal experimentation
3. Ethical issues in product development
4. 3D printed organs for healthcare applications
5. Wound care products
6. Blood derived products
7. Medical products from stem cells
8. Decellularised tissue products
9. Combinational products
10. Diagnostic assays as product development
11. Characterization of cells and animals used in experimentation
12. Product evaluation: Cytotoxicity assays
13. Product evaluation: Blood compatibility studies
14. Product evaluation: Microbial studies
15. Product evaluation: Safety and toxicity studies
16. Product evaluation: Histopathological studies
17. 3D printed organs for toxicity assays
18. Organ-on-a-chip for toxicity evaluation
19. In vitro alternative techniques
20. Neurotoxicity assay
21. Regulatory issues in biological products
22. Sterilization for biological products
2. Ethical issues in animal experimentation
3. Ethical issues in product development
4. 3D printed organs for healthcare applications
5. Wound care products
6. Blood derived products
7. Medical products from stem cells
8. Decellularised tissue products
9. Combinational products
10. Diagnostic assays as product development
11. Characterization of cells and animals used in experimentation
12. Product evaluation: Cytotoxicity assays
13. Product evaluation: Blood compatibility studies
14. Product evaluation: Microbial studies
15. Product evaluation: Safety and toxicity studies
16. Product evaluation: Histopathological studies
17. 3D printed organs for toxicity assays
18. Organ-on-a-chip for toxicity evaluation
19. In vitro alternative techniques
20. Neurotoxicity assay
21. Regulatory issues in biological products
22. Sterilization for biological products
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
2D cell culture; 3D bioprinting; 3D cell culture; 3D in vitro models; 3D printing; 3D-printing; 3R principles; ADMET; Acute wound; Albumin; Antibiotics; Antithrombin; Applications; Behavior; Behavioral screening test; Bifidobacterium; Biochemical assays; Biochemical reactions; Biocompatibility; Biodistribution studies; Bioink; Biological products; Biomaterials; Biomedical devices; Biomedical products; Bioprinting; Biosimilars; Blood-derived products; Blood-material interaction; Bone; Brain-on-a-chip; Cardiovascular; Cell adhesion; Cell culture; Cell cycle; Cell factories; Cell proliferation; Cell viability; Cell-cell interaction; Cell-matrix interaction; Ceramics; Chitosan; Chronic wound; Clinical trials; Coatings; Collagen; Colon cancer; Composites; Contamination; Cryoprecipitate; Cytocompatibility; Cytotoxicity; Dental caries; Depression; Design validation; Design verification; Developmental neurotoxicity; Drug discovery; Drug metabolism; Drug toxicity; Electrospinning; Epithelial-mesenchymal transition; Ethylene oxide sterilization; European Medicines Agency; Ex vivo models; Extrusion; FDA; Factor IX; Factor VIII; Factor X; Factor XI; Factor XIII; Fibrin glue; Fibrinogen; Fibronectin; Food and Drug Administration; Fresh frozen plasma; Functionalization; Gene and cellular therapy; Gross pathology; Growth factors; Hemocompatibility; Hemolysis; High-content analysis; Histopathology; Histotechniques; Horizontal standard; Humane endpoints; Hydrogels; ISO 10993-5; Image analysis; Imaging; Implantation sites; In silico prediction; In vitro assay; In vitro neurotoxicity; In vivo assay; In vivo neurotoxicity; Indian regulatory system; Inflammatory bowel diseases
1. Materials for medical products
2. Ethical issues in animal experimentation
3. Ethical issues in product development
4. 3D printed organs for healthcare applications
5. Wound care products
6. Blood derived products
7. Medical products from stem cells
8. Decellularised tissue products
9. Combinational products
10. Diagnostic assays as product development
11. Characterization of cells and animals used in experimentation
12. Product evaluation: Cytotoxicity assays
13. Product evaluation: Blood compatibility studies
14. Product evaluation: Microbial studies
15. Product evaluation: Safety and toxicity studies
16. Product evaluation: Histopathological studies
17. 3D printed organs for toxicity assays
18. Organ-on-a-chip for toxicity evaluation
19. In vitro alternative techniques
20. Neurotoxicity assay
21. Regulatory issues in biological products
22. Sterilization for biological products
2. Ethical issues in animal experimentation
3. Ethical issues in product development
4. 3D printed organs for healthcare applications
5. Wound care products
6. Blood derived products
7. Medical products from stem cells
8. Decellularised tissue products
9. Combinational products
10. Diagnostic assays as product development
11. Characterization of cells and animals used in experimentation
12. Product evaluation: Cytotoxicity assays
13. Product evaluation: Blood compatibility studies
14. Product evaluation: Microbial studies
15. Product evaluation: Safety and toxicity studies
16. Product evaluation: Histopathological studies
17. 3D printed organs for toxicity assays
18. Organ-on-a-chip for toxicity evaluation
19. In vitro alternative techniques
20. Neurotoxicity assay
21. Regulatory issues in biological products
22. Sterilization for biological products
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
2D cell culture; 3D bioprinting; 3D cell culture; 3D in vitro models; 3D printing; 3D-printing; 3R principles; ADMET; Acute wound; Albumin; Antibiotics; Antithrombin; Applications; Behavior; Behavioral screening test; Bifidobacterium; Biochemical assays; Biochemical reactions; Biocompatibility; Biodistribution studies; Bioink; Biological products; Biomaterials; Biomedical devices; Biomedical products; Bioprinting; Biosimilars; Blood-derived products; Blood-material interaction; Bone; Brain-on-a-chip; Cardiovascular; Cell adhesion; Cell culture; Cell cycle; Cell factories; Cell proliferation; Cell viability; Cell-cell interaction; Cell-matrix interaction; Ceramics; Chitosan; Chronic wound; Clinical trials; Coatings; Collagen; Colon cancer; Composites; Contamination; Cryoprecipitate; Cytocompatibility; Cytotoxicity; Dental caries; Depression; Design validation; Design verification; Developmental neurotoxicity; Drug discovery; Drug metabolism; Drug toxicity; Electrospinning; Epithelial-mesenchymal transition; Ethylene oxide sterilization; European Medicines Agency; Ex vivo models; Extrusion; FDA; Factor IX; Factor VIII; Factor X; Factor XI; Factor XIII; Fibrin glue; Fibrinogen; Fibronectin; Food and Drug Administration; Fresh frozen plasma; Functionalization; Gene and cellular therapy; Gross pathology; Growth factors; Hemocompatibility; Hemolysis; High-content analysis; Histopathology; Histotechniques; Horizontal standard; Humane endpoints; Hydrogels; ISO 10993-5; Image analysis; Imaging; Implantation sites; In silico prediction; In vitro assay; In vitro neurotoxicity; In vivo assay; In vivo neurotoxicity; Indian regulatory system; Inflammatory bowel diseases
